Ginwa Enterprise Group Inc (600080) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, Ginwa Enterprise Group Inc (600080) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥29.81 Million ≈ $4.36 Million USD) by net assets (CN¥1.58 Billion ≈ $231.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Ginwa Enterprise Group Inc (600080) market capitalisation for the company's overall valuation and market capitalisation.

Ginwa Enterprise Group Inc - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Ginwa Enterprise Group Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ginwa Enterprise Group Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ginwa Enterprise Group Inc ranked by their cash flow conversion efficiency. Explore Ginwa Enterprise Group Inc earnings quality ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Talon Capital Corp. Class A Ordinary Shares
NASDAQ:TLNC
-0.002x
Drugs Made In America Acquisition Corp. Ordinary Shares
NASDAQ:DMAA
-0.002x
Amtech Systems Inc
NASDAQ:ASYS
0.010x
Hunter Group ASA
OL:HUNT
0.512x
Ainsworth Game Technology Ltd
AU:AGI
-0.017x
PRG Corporation Public Company Limited
BK:PRG
-0.025x
Shanghai Baolijia Chemical Co. Ltd.
SHE:301037
N/A
Pruksa Holding Public Company Limited
BK:PSH
0.039x

Annual Cash Flow Conversion Efficiency for Ginwa Enterprise Group Inc (1998–2025)

The table below shows the annual cash flow conversion efficiency of Ginwa Enterprise Group Inc from 1998 to 2025. View Ginwa Enterprise Group Inc stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.56 Billion
≈ $228.04 Million
CN¥24.77 Million
≈ $3.62 Million
0.016x +128.23%
2024-12-31 CN¥1.56 Billion
≈ $228.20 Million
CN¥10.86 Million
≈ $1.59 Million
0.007x -81.16%
2023-12-31 CN¥1.64 Billion
≈ $239.75 Million
CN¥60.55 Million
≈ $8.86 Million
0.037x +18.34%
2022-12-31 CN¥1.68 Billion
≈ $246.39 Million
CN¥52.58 Million
≈ $7.69 Million
0.031x +69.04%
2021-12-31 CN¥1.66 Billion
≈ $242.36 Million
CN¥30.59 Million
≈ $4.48 Million
0.018x -31.70%
2020-12-31 CN¥1.72 Billion
≈ $251.89 Million
CN¥46.56 Million
≈ $6.81 Million
0.027x -58.36%
2019-12-31 CN¥1.72 Billion
≈ $251.06 Million
CN¥111.45 Million
≈ $16.31 Million
0.065x +294.35%
2018-12-31 CN¥1.77 Billion
≈ $259.22 Million
CN¥29.18 Million
≈ $4.27 Million
0.016x -57.02%
2017-12-31 CN¥1.12 Billion
≈ $163.66 Million
CN¥42.87 Million
≈ $6.27 Million
0.038x -1.25%
2016-12-31 CN¥1.07 Billion
≈ $157.13 Million
CN¥41.68 Million
≈ $6.10 Million
0.039x +33.85%
2015-12-31 CN¥1.05 Billion
≈ $153.06 Million
CN¥30.33 Million
≈ $4.44 Million
0.029x -13.83%
2014-12-31 CN¥1.02 Billion
≈ $149.29 Million
CN¥34.33 Million
≈ $5.02 Million
0.034x -23.57%
2013-12-31 CN¥998.35 Million
≈ $146.09 Million
CN¥43.96 Million
≈ $6.43 Million
0.044x +132.20%
2012-12-31 CN¥962.22 Million
≈ $140.80 Million
CN¥18.25 Million
≈ $2.67 Million
0.019x -80.86%
2011-12-31 CN¥918.45 Million
≈ $134.40 Million
CN¥91.02 Million
≈ $13.32 Million
0.099x +76.26%
2010-12-31 CN¥724.97 Million
≈ $106.09 Million
CN¥40.76 Million
≈ $5.96 Million
0.056x +3.91%
2009-12-31 CN¥691.57 Million
≈ $101.20 Million
CN¥37.42 Million
≈ $5.48 Million
0.054x -69.61%
2008-12-31 CN¥696.22 Million
≈ $101.88 Million
CN¥123.96 Million
≈ $18.14 Million
0.178x +1452.87%
2007-12-31 CN¥747.13 Million
≈ $109.33 Million
CN¥-9.83 Million
≈ $-1.44 Million
-0.013x -228.44%
2006-12-31 CN¥702.59 Million
≈ $102.81 Million
CN¥-2.82 Million
≈ $-411.98K
-0.004x +54.64%
2005-12-31 CN¥781.05 Million
≈ $114.29 Million
CN¥-6.90 Million
≈ $-1.01 Million
-0.009x -109.93%
2004-12-31 CN¥881.06 Million
≈ $128.93 Million
CN¥78.36 Million
≈ $11.47 Million
0.089x -0.45%
2003-12-31 CN¥869.84 Million
≈ $127.28 Million
CN¥77.72 Million
≈ $11.37 Million
0.089x +32.72%
2002-12-31 CN¥850.75 Million
≈ $124.49 Million
CN¥57.27 Million
≈ $8.38 Million
0.067x -30.49%
2001-12-31 CN¥829.75 Million
≈ $121.42 Million
CN¥80.36 Million
≈ $11.76 Million
0.097x -20.01%
2000-12-31 CN¥789.96 Million
≈ $115.60 Million
CN¥95.64 Million
≈ $14.00 Million
0.121x -2.80%
1999-12-31 CN¥480.99 Million
≈ $70.38 Million
CN¥59.91 Million
≈ $8.77 Million
0.125x -2.69%
1998-12-31 CN¥401.15 Million
≈ $58.70 Million
CN¥51.35 Million
≈ $7.51 Million
0.128x --

About Ginwa Enterprise Group Inc

SHG:600080 China Drug Manufacturers - Specialty & Generic
Market Cap
$262.18 Million
CN¥1.79 Billion CNY
Market Cap Rank
#15572 Global
#4579 in China
Share Price
CN¥4.80
Change (1 day)
-0.62%
52-Week Range
CN¥4.41 - CN¥9.16
All Time High
CN¥14.41
About

Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. It is also in… Read more